Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) General Information
Product name
Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11)
Validated applications
ELISA
Specificity
This product is a specific antibody specifically reacts with Eribulin.
Source
Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) is a Rabbit monoclonal antibody recombinantly expressed from HEK293 cells.
Purification
Protein A purified / Protein G purified
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant. Contact us for customized product form or formulation.
Conjugate
Unconjugated
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Recommended Usage
0.2-125 ng/mL
Note
MuseChem can customize this product per customer's request including product size, buffer components, etc.
Clone ID
1M2B11
Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) Images
Immobilized Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) (Cat. No. AB00013) at 1 μg/mL, add Farletuzumab Ecteribulin in the 100% Human Serum and then add Biotinylated Human FOLR1, Fc,Avitag at 0.5 μg/mL. Detection was performed using HRP-conjugated Streptavidin(QC tested).
Immobilized Farletuzumab Ecteribulin at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) (Cat. No. AB00013) with a linear range of 0.06-2 ng/mL (QC tested).
Serial dilutions of Eribulin were added into Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) (Cat. No.AB00013): Farletuzumab ecteribulin binding reactions. The half maximal inhibitory concentration (IC50) is 0.5451 μg/mL (Routinely tested).
ELISA binding of Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) (Cat. No. AB00013) with Disitamab Vedotin (RC48), Trastuzumab Deruxtecan, Sacituzumab Govitecam, Farletuzumab Ecteribulin, IgG1-MMAF and Trastuzumab-DM1 conjugated antibody respectively.
The coating antibody was Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) (Cat. No. AB00013), used at 1 μg/mL concentration. The primary antibody were different payload conjugated antibodies, including Disitamab Vedotin (RC48), Trastuzumab Deruxtecan, Sacituzumab Govitecam, Farletuzumab Ecteribulin, IgG1-MMAF and Trastuzumab-DM1 conjugated antibodies used at 0.5 μg/mL concentration. The secondary antibody was HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb used at 1:10000 concentration.
Monoclonal Anti-Eribulin Antibody, Rabbit IgG (1M2B11) (Cat. No. AB00013) is specific to Farletuzumab Ecteribulin, and has no cross-reactivity with Trastuzumab Deruxtecan, Sacituzumab Govitecam, Disitamab Vedotin (RC48), IgG1-MMAF and Trastuzumab-DM1 (Routinely tested).
